Are you looking to save the enormous effort and time involved in antibody engineering for pharmaceutical and diagnostic companies?
This service is an engineering service for improving antibody performance. It offers various technologies and achievements to accomplish different objectives, such as enhancing reactivity to lower concentrations of antigens, selecting clones with lower affinity, screening considering on-rate or off-rate, and engineering specificity by adding or removing cross-reactivity. 【Features of Our Service】 ■ Meeting customer needs that are difficult to fulfill elsewhere due to our extensive experience and high technical skills ■ Our technicians are Japanese, allowing for thorough discussions in Japanese before work begins ■ The rights to use antibody genes fully belong to the customer under a Fee For Service model ■ Proven track record with major pharmaceutical companies in the United States *Please feel free to contact us for more details.
Inquire About This Product
basic information
Abwiz Bio, for which we serve as the exclusive domestic agent, is a biotech venture company based in San Diego, California, specializing in recombinant antibody development and antibody engineering (established in 2013). They have established a development technology for recombinant rabbit monoclonal antibodies, which has been considered highly challenging, and their Affinity Maturation service is primarily utilized by major pharmaceutical companies in the United States. *For more details, please feel free to contact us.*
Price information
Please feel free to contact us.
Delivery Time
※Please contact us.
Applications/Examples of results
For more details, please contact us.
catalog（4）
Download All Catalogs
Company information
Since its founding, Kyokuto Pharmaceutical Industrial has supported the medical field in protecting human "health" through the manufacture and sale of bacterial culture media, media and reagents for bacterial testing, and clinical testing reagents and equipment. Looking to the future, we are now adding the perspective of "preventive medicine testing" to our traditional focus on "diagnostic and therapeutic testing." Based on the technologies and know-how accumulated in clinical testing, we are also venturing into the fields of cell culture-related products that serve as raw materials for advanced medicine and pharmaceuticals, as well as food and environmental testing, embarking on new challenges.